Test description
Testing of genes associated with inherited renal tumour and cystic disease syndromes, including VHL, in patients with renal cancer or suggestive clinical features.
Test information
BRAoVOTM Renal Gene panel
Used to determine a personal diagnosis of Von Hippel-Lindau (VHL) syndrome and family history of VHL/haemangioblastoma/phaeochromocytoma/renal cell carcinoma.
BAP1, EPCAM, FH, FLCN, MET, MLH1, MSH2, MSH6, PMS2, PTEN, SDHA, SDHAF2, SDHB, SDHC, SDHD, TSC1, TSC2, VHL, WT1
Massively parallel sequencing
4 - 5 weeks
73333 - conditions apply
$499 if not Medicare eligible
Cancer Genetics request form preferred. Standard pathology request form accepted.
Blood x 2
EDTA
2 x Bloods taken at 10 minute intervals. Pre-test genetic counselling required. Patient to provide consent prior to testing.